CCK8 negatively regulates the TLR9-induced activation of human peripheral blood pDCs by targeting TRAF6 signaling
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCK8 negatively regulates the TLR9-induced activation of human peripheral blood pDCs by targeting TRAF6 signaling
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 44, Issue 2, Pages 489-499
Publisher
Wiley
Online
2013-11-02
DOI
10.1002/eji.201343725
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cholecystokinin
- (2013) Graham J. Dockray Current Opinion in Endocrinology Diabetes and Obesity
- Functional niche of inflamed synovium for Th17-cell expansion and activation in rheumatoid arthritis: Implication to clinical therapeutics
- (2012) Weijia Dong et al. AUTOIMMUNITY REVIEWS
- Type I interferons in Sjögren's syndrome
- (2012) Yihong Yao et al. AUTOIMMUNITY REVIEWS
- The interferon signature in autoimmune diseases
- (2012) Lars Rönnblom et al. CURRENT OPINION IN RHEUMATOLOGY
- Monocyte-derived interferon-alpha primed dendritic cells in the pathogenesis of psoriasis: New pieces in the puzzle
- (2012) Árpád Farkas et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Production of Interferon α by Human Immunodeficiency Virus Type 1 in Human Plasmacytoid Dendritic Cells Is Dependent on Induction of Autophagy
- (2012) Dejiang Zhou et al. JOURNAL OF INFECTIOUS DISEASES
- Secondary damage caused by CD11b+ microglia following diffuse axonal injury in rats
- (2012) Xianxian Jia et al. Journal of Trauma and Acute Care Surgery
- The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-κB
- (2012) Monika Schneider et al. NATURE IMMUNOLOGY
- Plasmacytoid Dendritic Cells: Recent Progress and Open Questions
- (2011) Boris Reizis et al. Annual Review of Immunology
- Cholecystokinin octapeptide significantly suppresses collagen-induced arthritis in mice by inhibiting Th17 polarization primed by dendritic cells
- (2011) Qiaoxia Li et al. CELLULAR IMMUNOLOGY
- Cholecystokinin octapeptide inhibits immunoglobulin G1 production of lipopolysaccharide-activated B cells
- (2011) Jing-Ge Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis
- (2011) F. Jadidi-Niaragh et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- The type I IFN system in rheumatoid arthritis
- (2010) Paola Conigliaro et al. AUTOIMMUNITY
- Intracellular Toll-like Receptors
- (2010) Amanda L. Blasius et al. IMMUNITY
- Harnessing human dendritic cell subsets for medicine
- (2010) Hideki Ueno et al. IMMUNOLOGICAL REVIEWS
- Cholecystokinin octapeptide regulates lipopolysaccharide-activated B cells co-stimulatory molecule expression and cytokines production in vitro
- (2010) Jing-Ge Zhang et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- The CCK(-like) receptor in the animal kingdom: Functions, evolution and structures
- (2010) Dorien Staljanssens et al. PEPTIDES
- Cholecystokinin octapeptide exerts its therapeutic effects on collagen-induced arthritis by suppressing both inflammatory and Th17 responses
- (2010) Qiaoxia Li et al. RHEUMATOLOGY INTERNATIONAL
- Reciprocal role of GATA-1 and vitamin D receptor in human myeloid dendritic cell differentiation
- (2009) F. Gobel et al. BLOOD
- Th17 cells in rheumatoid arthritis and systemic lupus erythematosus
- (2009) A. B. Pernis JOURNAL OF INTERNAL MEDICINE
- Plasmacytoid Dendritic Cells Mediate Oral Tolerance
- (2008) Anne Goubier et al. IMMUNITY
- TRAF6 Autoubiquitination-Independent Activation of the NFκB and MAPK Pathways in Response to IL-1 and RANKL
- (2008) Matthew C. Walsh et al. PLoS One
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started